nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLC22A1—hematologic cancer	0.194	0.775	CbGaD
Indinavir—ABCB1—hematologic cancer	0.0564	0.225	CbGaD
Indinavir—ABCC1—Idarubicin—hematologic cancer	0.024	0.0461	CbGbCtD
Indinavir—SLCO1A2—Chlorambucil—hematologic cancer	0.0214	0.0412	CbGbCtD
Indinavir—ABCC1—Daunorubicin—hematologic cancer	0.017	0.0326	CbGbCtD
Indinavir—ABCC2—Daunorubicin—hematologic cancer	0.0126	0.0241	CbGbCtD
Indinavir—SLC22A1—Cytarabine—hematologic cancer	0.0118	0.0227	CbGbCtD
Indinavir—SLC22A1—Cladribine—hematologic cancer	0.0111	0.0214	CbGbCtD
Indinavir—ABCC1—Mitoxantrone—hematologic cancer	0.0103	0.0198	CbGbCtD
Indinavir—SLC22A1—Imatinib—hematologic cancer	0.0102	0.0197	CbGbCtD
Indinavir—ABCC1—Epirubicin—hematologic cancer	0.00834	0.016	CbGbCtD
Indinavir—ABCC1—Irinotecan—hematologic cancer	0.00811	0.0156	CbGbCtD
Indinavir—SLCO1A2—Prednisolone—hematologic cancer	0.00809	0.0156	CbGbCtD
Indinavir—SLCO1A2—Prednisone—hematologic cancer	0.00764	0.0147	CbGbCtD
Indinavir—ABCC1—Vinblastine—hematologic cancer	0.00721	0.0139	CbGbCtD
Indinavir—CYP2C9—Bexarotene—hematologic cancer	0.00719	0.0138	CbGbCtD
Indinavir—ABCC1—Vincristine—hematologic cancer	0.00709	0.0136	CbGbCtD
Indinavir—ABCB1—Lenalidomide—hematologic cancer	0.00698	0.0134	CbGbCtD
Indinavir—SLCO1B1—Irinotecan—hematologic cancer	0.00683	0.0131	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00672	0.0129	CbGbCtD
Indinavir—CYP3A7—Ifosfamide—hematologic cancer	0.00672	0.0129	CbGbCtD
Indinavir—ABCC1—Etoposide—hematologic cancer	0.0065	0.0125	CbGbCtD
Indinavir—CYP3A7—Imatinib—hematologic cancer	0.00642	0.0123	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00642	0.0123	CbGbCtD
Indinavir—CYP3A5—Daunorubicin—hematologic cancer	0.00629	0.0121	CbGbCtD
Indinavir—CYP2D6—Lomustine—hematologic cancer	0.00611	0.0118	CbGbCtD
Indinavir—ABCC2—Irinotecan—hematologic cancer	0.00601	0.0116	CbGbCtD
Indinavir—CYP2C9—Idarubicin—hematologic cancer	0.00596	0.0115	CbGbCtD
Indinavir—CYP3A5—Thalidomide—hematologic cancer	0.00573	0.011	CbGbCtD
Indinavir—CYP3A5—Teniposide—hematologic cancer	0.00546	0.0105	CbGbCtD
Indinavir—CYP2D6—Idarubicin—hematologic cancer	0.00545	0.0105	CbGbCtD
Indinavir—ABCC2—Vinblastine—hematologic cancer	0.00534	0.0103	CbGbCtD
Indinavir—CYP2C19—Bortezomib—hematologic cancer	0.0053	0.0102	CbGbCtD
Indinavir—ABCC2—Vincristine—hematologic cancer	0.00525	0.0101	CbGbCtD
Indinavir—CYP3A5—Ifosfamide—hematologic cancer	0.00504	0.0097	CbGbCtD
Indinavir—ABCC2—Cisplatin—hematologic cancer	0.0049	0.00942	CbGbCtD
Indinavir—CYP3A5—Imatinib—hematologic cancer	0.00482	0.00926	CbGbCtD
Indinavir—ABCC2—Etoposide—hematologic cancer	0.00481	0.00925	CbGbCtD
Indinavir—SLCO1A2—Dexamethasone—hematologic cancer	0.00477	0.00917	CbGbCtD
Indinavir—CYP2D6—Hydroxyurea—hematologic cancer	0.00463	0.00891	CbGbCtD
Indinavir—CYP2C19—Thalidomide—hematologic cancer	0.00462	0.00888	CbGbCtD
Indinavir—ABCC1—Doxorubicin—hematologic cancer	0.00443	0.00852	CbGbCtD
Indinavir—CYP2C9—Bortezomib—hematologic cancer	0.00441	0.00848	CbGbCtD
Indinavir—CYP2C19—Teniposide—hematologic cancer	0.00441	0.00847	CbGbCtD
Indinavir—ABCC1—Methotrexate—hematologic cancer	0.00429	0.00826	CbGbCtD
Indinavir—CYP3A4—Bexarotene—hematologic cancer	0.00418	0.00804	CbGbCtD
Indinavir—ABCB1—Daunorubicin—hematologic cancer	0.00409	0.00787	CbGbCtD
Indinavir—CYP2C19—Ifosfamide—hematologic cancer	0.00407	0.00782	CbGbCtD
Indinavir—CYP2D6—Bortezomib—hematologic cancer	0.00403	0.00775	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00401	0.00771	CbGbCtD
Indinavir—CYP3A7—Irinotecan—hematologic cancer	0.00401	0.00771	CbGbCtD
Indinavir—ABCB1—Alitretinoin—hematologic cancer	0.00401	0.00771	CbGbCtD
Indinavir—ABCC2—Dexamethasone—hematologic cancer	0.00395	0.00761	CbGbCtD
Indinavir—CYP3A4—Lomustine—hematologic cancer	0.00389	0.00748	CbGbCtD
Indinavir—CYP3A4—Busulfan—hematologic cancer	0.00389	0.00748	CbGbCtD
Indinavir—CYP2C19—Imatinib—hematologic cancer	0.00388	0.00747	CbGbCtD
Indinavir—CYP3A5—Dasatinib—hematologic cancer	0.00387	0.00744	CbGbCtD
Indinavir—CYP2C9—Thalidomide—hematologic cancer	0.00384	0.00739	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—hematologic cancer	0.00383	0.00737	CbGbCtD
Indinavir—CYP2C9—Teniposide—hematologic cancer	0.00366	0.00705	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—hematologic cancer	0.00362	0.00696	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00351	0.00674	CbGbCtD
Indinavir—CYP3A7—Vincristine—hematologic cancer	0.00351	0.00674	CbGbCtD
Indinavir—CYP3A4—Thiotepa—hematologic cancer	0.00347	0.00666	CbGbCtD
Indinavir—CYP2C9—Ifosfamide—hematologic cancer	0.00338	0.0065	CbGbCtD
Indinavir—ABCC2—Doxorubicin—hematologic cancer	0.00328	0.00631	CbGbCtD
Indinavir—CYP2C9—Imatinib—hematologic cancer	0.00323	0.00621	CbGbCtD
Indinavir—ABCC2—Methotrexate—hematologic cancer	0.00318	0.00611	CbGbCtD
Indinavir—ABCB1—Imatinib—hematologic cancer	0.00313	0.00603	CbGbCtD
Indinavir—CYP3A5—Irinotecan—hematologic cancer	0.00301	0.00579	CbGbCtD
Indinavir—CYP2D6—Imatinib—hematologic cancer	0.00295	0.00568	CbGbCtD
Indinavir—CYP2C9—Nilotinib—hematologic cancer	0.00294	0.00564	CbGbCtD
Indinavir—ABCB1—Nilotinib—hematologic cancer	0.00285	0.00548	CbGbCtD
Indinavir—ABCB1—Vinorelbine—hematologic cancer	0.00282	0.00543	CbGbCtD
Indinavir—CYP3A4—Methoxsalen—hematologic cancer	0.00269	0.00518	CbGbCtD
Indinavir—CYP2D6—Nilotinib—hematologic cancer	0.00268	0.00516	CbGbCtD
Indinavir—CYP2D6—Vinorelbine—hematologic cancer	0.00266	0.00512	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00264	0.00508	CbGbCtD
Indinavir—CYP3A7—Dexamethasone—hematologic cancer	0.00264	0.00508	CbGbCtD
Indinavir—CYP3A5—Vincristine—hematologic cancer	0.00263	0.00506	CbGbCtD
Indinavir—CYP3A4—Bortezomib—hematologic cancer	0.00256	0.00493	CbGbCtD
Indinavir—CYP2C19—Prednisone—hematologic cancer	0.00256	0.00492	CbGbCtD
Indinavir—ABCB1—Dasatinib—hematologic cancer	0.00252	0.00484	CbGbCtD
Indinavir—ABCB1—Mitoxantrone—hematologic cancer	0.00249	0.00478	CbGbCtD
Indinavir—CYP3A4—Daunorubicin—hematologic cancer	0.00245	0.00472	CbGbCtD
Indinavir—CYP3A5—Etoposide—hematologic cancer	0.00241	0.00463	CbGbCtD
Indinavir—ABCB1—Betamethasone—hematologic cancer	0.00222	0.00426	CbGbCtD
Indinavir—ABCB1—Gemcitabine—hematologic cancer	0.0022	0.00422	CbGbCtD
Indinavir—ABCB1—Prednisolone—hematologic cancer	0.00219	0.00421	CbGbCtD
Indinavir—CYP3A4—Cytarabine—hematologic cancer	0.00216	0.00416	CbGbCtD
Indinavir—CYP3A4—Teniposide—hematologic cancer	0.00213	0.0041	CbGbCtD
Indinavir—ABCB1—Prednisone—hematologic cancer	0.00207	0.00397	CbGbCtD
Indinavir—CYP3A5—Dexamethasone—hematologic cancer	0.00198	0.00381	CbGbCtD
Indinavir—CYP3A4—Ifosfamide—hematologic cancer	0.00197	0.00378	CbGbCtD
Indinavir—ABCB1—Irinotecan—hematologic cancer	0.00196	0.00377	CbGbCtD
Indinavir—CYP3A4—Imatinib—hematologic cancer	0.00188	0.00361	CbGbCtD
Indinavir—CYP3A4—Ruxolitinib—hematologic cancer	0.00177	0.0034	CbGbCtD
Indinavir—ABCB1—Vinblastine—hematologic cancer	0.00174	0.00335	CbGbCtD
Indinavir—ABCB1—Vincristine—hematologic cancer	0.00171	0.00329	CbGbCtD
Indinavir—CYP3A4—Nilotinib—hematologic cancer	0.00171	0.00328	CbGbCtD
Indinavir—CYP3A4—Vinorelbine—hematologic cancer	0.00169	0.00325	CbGbCtD
Indinavir—CYP2C9—Cisplatin—hematologic cancer	0.00164	0.00316	CbGbCtD
Indinavir—CYP2D6—Vinblastine—hematologic cancer	0.00164	0.00315	CbGbCtD
Indinavir—CYP2C19—Dexamethasone—hematologic cancer	0.0016	0.00307	CbGbCtD
Indinavir—ABCB1—Cisplatin—hematologic cancer	0.0016	0.00307	CbGbCtD
Indinavir—ABCB1—Etoposide—hematologic cancer	0.00157	0.00302	CbGbCtD
Indinavir—CYP3A4—Triamcinolone—hematologic cancer	0.00155	0.00298	CbGbCtD
Indinavir—CYP3A4—Dasatinib—hematologic cancer	0.00151	0.0029	CbGbCtD
Indinavir—CYP3A4—Mitoxantrone—hematologic cancer	0.00149	0.00287	CbGbCtD
Indinavir—CYP2C9—Dexamethasone—hematologic cancer	0.00133	0.00255	CbGbCtD
Indinavir—CYP3A4—Betamethasone—hematologic cancer	0.00133	0.00255	CbGbCtD
Indinavir—CYP3A4—Prednisolone—hematologic cancer	0.00131	0.00252	CbGbCtD
Indinavir—ABCB1—Dexamethasone—hematologic cancer	0.00129	0.00248	CbGbCtD
Indinavir—CYP3A4—Prednisone—hematologic cancer	0.00124	0.00238	CbGbCtD
Indinavir—CYP2D6—Dexamethasone—hematologic cancer	0.00121	0.00234	CbGbCtD
Indinavir—CYP3A4—Irinotecan—hematologic cancer	0.00117	0.00226	CbGbCtD
Indinavir—ABCB1—Doxorubicin—hematologic cancer	0.00107	0.00206	CbGbCtD
Indinavir—CYP3A4—Vinblastine—hematologic cancer	0.00104	0.00201	CbGbCtD
Indinavir—ABCB1—Methotrexate—hematologic cancer	0.00104	0.00199	CbGbCtD
Indinavir—CYP3A4—Vincristine—hematologic cancer	0.00103	0.00197	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—hematologic cancer	0.00101	0.00194	CbGbCtD
Indinavir—CYP3A4—Etoposide—hematologic cancer	0.00094	0.00181	CbGbCtD
Indinavir—CYP3A4—Dexamethasone—hematologic cancer	0.000772	0.00149	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—hematologic cancer	0.000641	0.00123	CbGbCtD
Indinavir—Nelfinavir—SLC22A1—hematologic cancer	0.000569	0.258	CrCbGaD
Indinavir—Nelfinavir—ABCG2—hematologic cancer	0.000398	0.18	CrCbGaD
Indinavir—Saquinavir—SLC22A1—hematologic cancer	0.00039	0.177	CrCbGaD
Indinavir—SLCO1B1—hematopoietic system—hematologic cancer	0.00034	0.0804	CbGeAlD
Indinavir—SLCO1A2—hematopoietic system—hematologic cancer	0.000277	0.0654	CbGeAlD
Indinavir—Saquinavir—ABCG2—hematologic cancer	0.000273	0.124	CrCbGaD
Indinavir—SLCO1B1—blood—hematologic cancer	0.000225	0.0532	CbGeAlD
Indinavir—CYP2C19—hematopoietic system—hematologic cancer	0.000222	0.0524	CbGeAlD
Indinavir—SLC22A1—blood—hematologic cancer	0.00019	0.045	CbGeAlD
Indinavir—Lopinavir—ABCB1—hematologic cancer	0.000178	0.0807	CrCbGaD
Indinavir—CYP3A5—hematopoietic system—hematologic cancer	0.000175	0.0412	CbGeAlD
Indinavir—CYP2C9—hematopoietic system—hematologic cancer	0.000172	0.0406	CbGeAlD
Indinavir—ABCC2—blood—hematologic cancer	0.000171	0.0404	CbGeAlD
Indinavir—Nelfinavir—ABCB1—hematologic cancer	0.000166	0.075	CrCbGaD
Indinavir—SLCO1A2—lung—hematologic cancer	0.000161	0.038	CbGeAlD
Indinavir—SLCO1A2—testis—hematologic cancer	0.000152	0.0358	CbGeAlD
Indinavir—ABCC1—blood—hematologic cancer	0.00015	0.0356	CbGeAlD
Indinavir—CYP2C19—blood—hematologic cancer	0.000147	0.0347	CbGeAlD
Indinavir—ABCC2—testis—hematologic cancer	0.000141	0.0334	CbGeAlD
Indinavir—ABCC1—lung—hematologic cancer	0.000132	0.0312	CbGeAlD
Indinavir—CYP3A4—hematopoietic system—hematologic cancer	0.000131	0.031	CbGeAlD
Indinavir—CYP2D6—hematopoietic system—hematologic cancer	0.000129	0.0305	CbGeAlD
Indinavir—ABCC1—testis—hematologic cancer	0.000124	0.0294	CbGeAlD
Indinavir—Saquinavir—ALB—hematologic cancer	0.000119	0.0539	CrCbGaD
Indinavir—CYP3A5—blood—hematologic cancer	0.000116	0.0273	CbGeAlD
Indinavir—CYP2C9—blood—hematologic cancer	0.000114	0.0269	CbGeAlD
Indinavir—Saquinavir—ABCB1—hematologic cancer	0.000113	0.0514	CrCbGaD
Indinavir—ABCC2—lymph node—hematologic cancer	0.000102	0.0242	CbGeAlD
Indinavir—CYP3A5—lung—hematologic cancer	0.000101	0.024	CbGeAlD
Indinavir—ABCB1—hematopoietic system—hematologic cancer	9.27e-05	0.0219	CbGeAlD
Indinavir—ABCC1—lymph node—hematologic cancer	9.02e-05	0.0213	CbGeAlD
Indinavir—CYP3A4—blood—hematologic cancer	8.68e-05	0.0205	CbGeAlD
Indinavir—CYP2D6—blood—hematologic cancer	8.54e-05	0.0202	CbGeAlD
Indinavir—CYP2D6—testis—hematologic cancer	7.06e-05	0.0167	CbGeAlD
Indinavir—ABCB1—gonad—hematologic cancer	7.05e-05	0.0167	CbGeAlD
Indinavir—ABCB1—blood—hematologic cancer	6.14e-05	0.0145	CbGeAlD
Indinavir—ABCB1—bone marrow—hematologic cancer	5.94e-05	0.014	CbGeAlD
Indinavir—ABCB1—lung—hematologic cancer	5.38e-05	0.0127	CbGeAlD
Indinavir—ABCB1—testis—hematologic cancer	5.08e-05	0.012	CbGeAlD
Indinavir—ABCB1—lymph node—hematologic cancer	3.68e-05	0.0087	CbGeAlD
Indinavir—Fatigue—Betamethasone—hematologic cancer	1.47e-05	8.07e-05	CcSEcCtD
Indinavir—Chills—Epirubicin—hematologic cancer	1.47e-05	8.05e-05	CcSEcCtD
Indinavir—Pruritus—Etoposide—hematologic cancer	1.47e-05	8.05e-05	CcSEcCtD
Indinavir—Shock—Prednisone—hematologic cancer	1.46e-05	8.02e-05	CcSEcCtD
Indinavir—Pain—Dexamethasone—hematologic cancer	1.46e-05	8.01e-05	CcSEcCtD
Indinavir—Pain—Betamethasone—hematologic cancer	1.46e-05	8.01e-05	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—hematologic cancer	1.46e-05	8e-05	CcSEcCtD
Indinavir—Alopecia—Epirubicin—hematologic cancer	1.45e-05	7.93e-05	CcSEcCtD
Indinavir—Skin disorder—Prednisone—hematologic cancer	1.44e-05	7.92e-05	CcSEcCtD
Indinavir—Nausea—Gemcitabine—hematologic cancer	1.44e-05	7.91e-05	CcSEcCtD
Indinavir—Vomiting—Cisplatin—hematologic cancer	1.44e-05	7.9e-05	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—hematologic cancer	1.44e-05	7.88e-05	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—hematologic cancer	1.43e-05	7.87e-05	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—hematologic cancer	1.43e-05	7.85e-05	CcSEcCtD
Indinavir—Rash—Cisplatin—hematologic cancer	1.43e-05	7.83e-05	CcSEcCtD
Indinavir—Dermatitis—Cisplatin—hematologic cancer	1.43e-05	7.82e-05	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—hematologic cancer	1.42e-05	7.81e-05	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—hematologic cancer	1.42e-05	7.78e-05	CcSEcCtD
Indinavir—Anorexia—Prednisone—hematologic cancer	1.42e-05	7.77e-05	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—hematologic cancer	1.41e-05	7.75e-05	CcSEcCtD
Indinavir—Anaemia—Methotrexate—hematologic cancer	1.41e-05	7.72e-05	CcSEcCtD
Indinavir—Feeling abnormal—Betamethasone—hematologic cancer	1.41e-05	7.72e-05	CcSEcCtD
Indinavir—Feeling abnormal—Dexamethasone—hematologic cancer	1.41e-05	7.72e-05	CcSEcCtD
Indinavir—Flushing—Doxorubicin—hematologic cancer	1.41e-05	7.71e-05	CcSEcCtD
Indinavir—Flatulence—Epirubicin—hematologic cancer	1.4e-05	7.7e-05	CcSEcCtD
Indinavir—Tension—Epirubicin—hematologic cancer	1.4e-05	7.67e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.4e-05	7.66e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Betamethasone—hematologic cancer	1.4e-05	7.66e-05	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—hematologic cancer	1.39e-05	7.65e-05	CcSEcCtD
Indinavir—Hypersensitivity—Triamcinolone—hematologic cancer	1.39e-05	7.6e-05	CcSEcCtD
Indinavir—Nervousness—Epirubicin—hematologic cancer	1.38e-05	7.59e-05	CcSEcCtD
Indinavir—Back pain—Epirubicin—hematologic cancer	1.38e-05	7.56e-05	CcSEcCtD
Indinavir—Malaise—Methotrexate—hematologic cancer	1.37e-05	7.53e-05	CcSEcCtD
Indinavir—Dizziness—Etoposide—hematologic cancer	1.37e-05	7.52e-05	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—hematologic cancer	1.37e-05	7.51e-05	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—hematologic cancer	1.37e-05	7.5e-05	CcSEcCtD
Indinavir—Vertigo—Methotrexate—hematologic cancer	1.37e-05	7.5e-05	CcSEcCtD
Indinavir—Chills—Doxorubicin—hematologic cancer	1.36e-05	7.45e-05	CcSEcCtD
Indinavir—Urticaria—Betamethasone—hematologic cancer	1.36e-05	7.44e-05	CcSEcCtD
Indinavir—Urticaria—Dexamethasone—hematologic cancer	1.36e-05	7.44e-05	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.35e-05	7.43e-05	CcSEcCtD
Indinavir—Dizziness—Prednisolone—hematologic cancer	1.35e-05	7.42e-05	CcSEcCtD
Indinavir—Asthenia—Triamcinolone—hematologic cancer	1.35e-05	7.4e-05	CcSEcCtD
Indinavir—Body temperature increased—Dexamethasone—hematologic cancer	1.35e-05	7.4e-05	CcSEcCtD
Indinavir—Abdominal pain—Dexamethasone—hematologic cancer	1.35e-05	7.4e-05	CcSEcCtD
Indinavir—Body temperature increased—Betamethasone—hematologic cancer	1.35e-05	7.4e-05	CcSEcCtD
Indinavir—Abdominal pain—Betamethasone—hematologic cancer	1.35e-05	7.4e-05	CcSEcCtD
Indinavir—Nausea—Cisplatin—hematologic cancer	1.34e-05	7.38e-05	CcSEcCtD
Indinavir—Insomnia—Prednisone—hematologic cancer	1.34e-05	7.37e-05	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—hematologic cancer	1.34e-05	7.36e-05	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—hematologic cancer	1.34e-05	7.34e-05	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—hematologic cancer	1.33e-05	7.32e-05	CcSEcCtD
Indinavir—Pruritus—Triamcinolone—hematologic cancer	1.33e-05	7.3e-05	CcSEcCtD
Indinavir—Cough—Methotrexate—hematologic cancer	1.33e-05	7.29e-05	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—hematologic cancer	1.32e-05	7.25e-05	CcSEcCtD
Indinavir—Vomiting—Etoposide—hematologic cancer	1.32e-05	7.23e-05	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—hematologic cancer	1.32e-05	7.23e-05	CcSEcCtD
Indinavir—Anaemia—Epirubicin—hematologic cancer	1.32e-05	7.22e-05	CcSEcCtD
Indinavir—Agitation—Epirubicin—hematologic cancer	1.31e-05	7.18e-05	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—hematologic cancer	1.31e-05	7.18e-05	CcSEcCtD
Indinavir—Rash—Etoposide—hematologic cancer	1.31e-05	7.17e-05	CcSEcCtD
Indinavir—Dermatitis—Etoposide—hematologic cancer	1.31e-05	7.17e-05	CcSEcCtD
Indinavir—Headache—Etoposide—hematologic cancer	1.3e-05	7.13e-05	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—hematologic cancer	1.3e-05	7.12e-05	CcSEcCtD
Indinavir—Chest pain—Methotrexate—hematologic cancer	1.3e-05	7.11e-05	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—hematologic cancer	1.3e-05	7.11e-05	CcSEcCtD
Indinavir—Myalgia—Methotrexate—hematologic cancer	1.3e-05	7.11e-05	CcSEcCtD
Indinavir—Tension—Doxorubicin—hematologic cancer	1.29e-05	7.09e-05	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—hematologic cancer	1.29e-05	7.09e-05	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—hematologic cancer	1.29e-05	7.08e-05	CcSEcCtD
Indinavir—Rash—Prednisolone—hematologic cancer	1.29e-05	7.07e-05	CcSEcCtD
Indinavir—Dermatitis—Prednisolone—hematologic cancer	1.29e-05	7.07e-05	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.29e-05	7.06e-05	CcSEcCtD
Indinavir—Malaise—Epirubicin—hematologic cancer	1.28e-05	7.05e-05	CcSEcCtD
Indinavir—Fatigue—Prednisone—hematologic cancer	1.28e-05	7.03e-05	CcSEcCtD
Indinavir—Headache—Prednisolone—hematologic cancer	1.28e-05	7.03e-05	CcSEcCtD
Indinavir—Discomfort—Methotrexate—hematologic cancer	1.28e-05	7.02e-05	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—hematologic cancer	1.28e-05	7.02e-05	CcSEcCtD
Indinavir—Vertigo—Epirubicin—hematologic cancer	1.28e-05	7.02e-05	CcSEcCtD
Indinavir—Syncope—Epirubicin—hematologic cancer	1.28e-05	7.01e-05	CcSEcCtD
Indinavir—Back pain—Doxorubicin—hematologic cancer	1.27e-05	6.99e-05	CcSEcCtD
Indinavir—Constipation—Prednisone—hematologic cancer	1.27e-05	6.97e-05	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—hematologic cancer	1.27e-05	6.95e-05	CcSEcCtD
Indinavir—Palpitations—Epirubicin—hematologic cancer	1.26e-05	6.91e-05	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—hematologic cancer	1.25e-05	6.87e-05	CcSEcCtD
Indinavir—Dizziness—Triamcinolone—hematologic cancer	1.24e-05	6.82e-05	CcSEcCtD
Indinavir—Cough—Epirubicin—hematologic cancer	1.24e-05	6.82e-05	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—hematologic cancer	1.24e-05	6.81e-05	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—hematologic cancer	1.24e-05	6.81e-05	CcSEcCtD
Indinavir—Nausea—Etoposide—hematologic cancer	1.23e-05	6.76e-05	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—hematologic cancer	1.22e-05	6.72e-05	CcSEcCtD
Indinavir—Asthenia—Dexamethasone—hematologic cancer	1.22e-05	6.72e-05	CcSEcCtD
Indinavir—Asthenia—Betamethasone—hematologic cancer	1.22e-05	6.72e-05	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—hematologic cancer	1.22e-05	6.71e-05	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—hematologic cancer	1.22e-05	6.68e-05	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—hematologic cancer	1.22e-05	6.68e-05	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—hematologic cancer	1.22e-05	6.67e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—hematologic cancer	1.22e-05	6.67e-05	CcSEcCtD
Indinavir—Nausea—Prednisolone—hematologic cancer	1.21e-05	6.66e-05	CcSEcCtD
Indinavir—Chest pain—Epirubicin—hematologic cancer	1.21e-05	6.65e-05	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—hematologic cancer	1.21e-05	6.65e-05	CcSEcCtD
Indinavir—Myalgia—Epirubicin—hematologic cancer	1.21e-05	6.65e-05	CcSEcCtD
Indinavir—Agitation—Doxorubicin—hematologic cancer	1.21e-05	6.64e-05	CcSEcCtD
Indinavir—Anxiety—Epirubicin—hematologic cancer	1.21e-05	6.63e-05	CcSEcCtD
Indinavir—Pruritus—Betamethasone—hematologic cancer	1.21e-05	6.62e-05	CcSEcCtD
Indinavir—Pruritus—Dexamethasone—hematologic cancer	1.21e-05	6.62e-05	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—hematologic cancer	1.21e-05	6.62e-05	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.2e-05	6.61e-05	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—hematologic cancer	1.2e-05	6.59e-05	CcSEcCtD
Indinavir—Discomfort—Epirubicin—hematologic cancer	1.2e-05	6.57e-05	CcSEcCtD
Indinavir—Vomiting—Triamcinolone—hematologic cancer	1.2e-05	6.56e-05	CcSEcCtD
Indinavir—Malaise—Doxorubicin—hematologic cancer	1.19e-05	6.52e-05	CcSEcCtD
Indinavir—Rash—Triamcinolone—hematologic cancer	1.19e-05	6.51e-05	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—hematologic cancer	1.19e-05	6.51e-05	CcSEcCtD
Indinavir—Dermatitis—Triamcinolone—hematologic cancer	1.18e-05	6.5e-05	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—hematologic cancer	1.18e-05	6.5e-05	CcSEcCtD
Indinavir—Anorexia—Methotrexate—hematologic cancer	1.18e-05	6.5e-05	CcSEcCtD
Indinavir—Syncope—Doxorubicin—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Indinavir—Urticaria—Prednisone—hematologic cancer	1.18e-05	6.48e-05	CcSEcCtD
Indinavir—Headache—Triamcinolone—hematologic cancer	1.18e-05	6.46e-05	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—hematologic cancer	1.17e-05	6.45e-05	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—hematologic cancer	1.17e-05	6.45e-05	CcSEcCtD
Indinavir—Diarrhoea—Dexamethasone—hematologic cancer	1.17e-05	6.41e-05	CcSEcCtD
Indinavir—Diarrhoea—Betamethasone—hematologic cancer	1.17e-05	6.41e-05	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—hematologic cancer	1.16e-05	6.39e-05	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—hematologic cancer	1.16e-05	6.38e-05	CcSEcCtD
Indinavir—Oedema—Epirubicin—hematologic cancer	1.16e-05	6.38e-05	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—hematologic cancer	1.16e-05	6.35e-05	CcSEcCtD
Indinavir—Cough—Doxorubicin—hematologic cancer	1.15e-05	6.31e-05	CcSEcCtD
Indinavir—Shock—Epirubicin—hematologic cancer	1.14e-05	6.27e-05	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—hematologic cancer	1.14e-05	6.25e-05	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—hematologic cancer	1.14e-05	6.24e-05	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.13e-05	6.21e-05	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—hematologic cancer	1.13e-05	6.19e-05	CcSEcCtD
Indinavir—Dizziness—Dexamethasone—hematologic cancer	1.13e-05	6.19e-05	CcSEcCtD
Indinavir—Dizziness—Betamethasone—hematologic cancer	1.13e-05	6.19e-05	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—hematologic cancer	1.12e-05	6.16e-05	CcSEcCtD
Indinavir—Insomnia—Methotrexate—hematologic cancer	1.12e-05	6.16e-05	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—hematologic cancer	1.12e-05	6.16e-05	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—hematologic cancer	1.12e-05	6.16e-05	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—hematologic cancer	1.12e-05	6.16e-05	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—hematologic cancer	1.12e-05	6.13e-05	CcSEcCtD
Indinavir—Nausea—Triamcinolone—hematologic cancer	1.12e-05	6.13e-05	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—hematologic cancer	1.12e-05	6.12e-05	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.11e-05	6.11e-05	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—hematologic cancer	1.11e-05	6.08e-05	CcSEcCtD
Indinavir—Anorexia—Epirubicin—hematologic cancer	1.11e-05	6.08e-05	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—hematologic cancer	1.11e-05	6.08e-05	CcSEcCtD
Indinavir—Somnolence—Methotrexate—hematologic cancer	1.1e-05	6.06e-05	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—hematologic cancer	1.1e-05	6.02e-05	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—hematologic cancer	1.1e-05	6.01e-05	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—hematologic cancer	1.09e-05	6e-05	CcSEcCtD
Indinavir—Vomiting—Dexamethasone—hematologic cancer	1.09e-05	5.95e-05	CcSEcCtD
Indinavir—Vomiting—Betamethasone—hematologic cancer	1.09e-05	5.95e-05	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—hematologic cancer	1.08e-05	5.92e-05	CcSEcCtD
Indinavir—Rash—Dexamethasone—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Rash—Betamethasone—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Oedema—Doxorubicin—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Dermatitis—Betamethasone—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Dermatitis—Dexamethasone—hematologic cancer	1.08e-05	5.9e-05	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.07e-05	5.88e-05	CcSEcCtD
Indinavir—Fatigue—Methotrexate—hematologic cancer	1.07e-05	5.88e-05	CcSEcCtD
Indinavir—Headache—Dexamethasone—hematologic cancer	1.07e-05	5.87e-05	CcSEcCtD
Indinavir—Headache—Betamethasone—hematologic cancer	1.07e-05	5.87e-05	CcSEcCtD
Indinavir—Asthenia—Prednisone—hematologic cancer	1.07e-05	5.85e-05	CcSEcCtD
Indinavir—Pain—Methotrexate—hematologic cancer	1.06e-05	5.83e-05	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.06e-05	5.81e-05	CcSEcCtD
Indinavir—Shock—Doxorubicin—hematologic cancer	1.06e-05	5.81e-05	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—hematologic cancer	1.05e-05	5.79e-05	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—hematologic cancer	1.05e-05	5.78e-05	CcSEcCtD
Indinavir—Pruritus—Prednisone—hematologic cancer	1.05e-05	5.77e-05	CcSEcCtD
Indinavir—Insomnia—Epirubicin—hematologic cancer	1.05e-05	5.77e-05	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—hematologic cancer	1.04e-05	5.73e-05	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—hematologic cancer	1.04e-05	5.73e-05	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—hematologic cancer	1.04e-05	5.7e-05	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—hematologic cancer	1.04e-05	5.69e-05	CcSEcCtD
Indinavir—Somnolence—Epirubicin—hematologic cancer	1.03e-05	5.67e-05	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—hematologic cancer	1.03e-05	5.62e-05	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—hematologic cancer	1.02e-05	5.62e-05	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—hematologic cancer	1.02e-05	5.61e-05	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—hematologic cancer	1.02e-05	5.58e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—hematologic cancer	1.02e-05	5.57e-05	CcSEcCtD
Indinavir—Nausea—Betamethasone—hematologic cancer	1.01e-05	5.56e-05	CcSEcCtD
Indinavir—Nausea—Dexamethasone—hematologic cancer	1.01e-05	5.56e-05	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—hematologic cancer	1.01e-05	5.54e-05	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—hematologic cancer	1e-05	5.51e-05	CcSEcCtD
Indinavir—Fatigue—Epirubicin—hematologic cancer	1e-05	5.5e-05	CcSEcCtD
Indinavir—Pain—Epirubicin—hematologic cancer	9.94e-06	5.45e-05	CcSEcCtD
Indinavir—Constipation—Epirubicin—hematologic cancer	9.94e-06	5.45e-05	CcSEcCtD
Indinavir—Urticaria—Methotrexate—hematologic cancer	9.87e-06	5.41e-05	CcSEcCtD
Indinavir—Dizziness—Prednisone—hematologic cancer	9.83e-06	5.39e-05	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—hematologic cancer	9.82e-06	5.39e-05	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—hematologic cancer	9.82e-06	5.39e-05	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.8e-06	5.38e-05	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—hematologic cancer	9.73e-06	5.34e-05	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—hematologic cancer	9.66e-06	5.3e-05	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—hematologic cancer	9.59e-06	5.26e-05	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—hematologic cancer	9.58e-06	5.26e-05	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—hematologic cancer	9.56e-06	5.25e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—hematologic cancer	9.51e-06	5.21e-05	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—hematologic cancer	9.47e-06	5.19e-05	CcSEcCtD
Indinavir—Vomiting—Prednisone—hematologic cancer	9.45e-06	5.18e-05	CcSEcCtD
Indinavir—Rash—Prednisone—hematologic cancer	9.37e-06	5.14e-05	CcSEcCtD
Indinavir—Dermatitis—Prednisone—hematologic cancer	9.36e-06	5.14e-05	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—hematologic cancer	9.35e-06	5.13e-05	CcSEcCtD
Indinavir—Headache—Prednisone—hematologic cancer	9.31e-06	5.11e-05	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.29e-06	5.09e-05	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—hematologic cancer	9.27e-06	5.09e-05	CcSEcCtD
Indinavir—Urticaria—Epirubicin—hematologic cancer	9.24e-06	5.07e-05	CcSEcCtD
Indinavir—Pain—Doxorubicin—hematologic cancer	9.2e-06	5.05e-05	CcSEcCtD
Indinavir—Constipation—Doxorubicin—hematologic cancer	9.2e-06	5.05e-05	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—hematologic cancer	9.19e-06	5.04e-05	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—hematologic cancer	9.19e-06	5.04e-05	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—hematologic cancer	9.15e-06	5.02e-05	CcSEcCtD
Indinavir—Asthenia—Methotrexate—hematologic cancer	8.91e-06	4.89e-05	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—hematologic cancer	8.86e-06	4.86e-05	CcSEcCtD
Indinavir—Nausea—Prednisone—hematologic cancer	8.83e-06	4.84e-05	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.8e-06	4.83e-05	CcSEcCtD
Indinavir—Pruritus—Methotrexate—hematologic cancer	8.79e-06	4.82e-05	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—hematologic cancer	8.56e-06	4.7e-05	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—hematologic cancer	8.54e-06	4.69e-05	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—hematologic cancer	8.5e-06	4.66e-05	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—hematologic cancer	8.5e-06	4.66e-05	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—hematologic cancer	8.5e-06	4.66e-05	CcSEcCtD
Indinavir—Asthenia—Epirubicin—hematologic cancer	8.34e-06	4.58e-05	CcSEcCtD
Indinavir—Pruritus—Epirubicin—hematologic cancer	8.22e-06	4.51e-05	CcSEcCtD
Indinavir—Dizziness—Methotrexate—hematologic cancer	8.21e-06	4.51e-05	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—hematologic cancer	7.95e-06	4.36e-05	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—hematologic cancer	7.92e-06	4.35e-05	CcSEcCtD
Indinavir—Vomiting—Methotrexate—hematologic cancer	7.9e-06	4.33e-05	CcSEcCtD
Indinavir—Rash—Methotrexate—hematologic cancer	7.83e-06	4.3e-05	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—hematologic cancer	7.83e-06	4.29e-05	CcSEcCtD
Indinavir—Headache—Methotrexate—hematologic cancer	7.78e-06	4.27e-05	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—hematologic cancer	7.72e-06	4.23e-05	CcSEcCtD
Indinavir—Dizziness—Epirubicin—hematologic cancer	7.69e-06	4.22e-05	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—hematologic cancer	7.61e-06	4.17e-05	CcSEcCtD
Indinavir—Vomiting—Epirubicin—hematologic cancer	7.39e-06	4.05e-05	CcSEcCtD
Indinavir—Nausea—Methotrexate—hematologic cancer	7.38e-06	4.05e-05	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—hematologic cancer	7.36e-06	4.04e-05	CcSEcCtD
Indinavir—Rash—Epirubicin—hematologic cancer	7.33e-06	4.02e-05	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—hematologic cancer	7.32e-06	4.02e-05	CcSEcCtD
Indinavir—Headache—Epirubicin—hematologic cancer	7.28e-06	4e-05	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—hematologic cancer	7.11e-06	3.9e-05	CcSEcCtD
Indinavir—Nausea—Epirubicin—hematologic cancer	6.91e-06	3.79e-05	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—hematologic cancer	6.84e-06	3.75e-05	CcSEcCtD
Indinavir—Rash—Doxorubicin—hematologic cancer	6.78e-06	3.72e-05	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—hematologic cancer	6.78e-06	3.72e-05	CcSEcCtD
Indinavir—Headache—Doxorubicin—hematologic cancer	6.74e-06	3.7e-05	CcSEcCtD
Indinavir—Nausea—Doxorubicin—hematologic cancer	6.39e-06	3.5e-05	CcSEcCtD
Indinavir—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.57e-06	8.73e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ENO2—hematologic cancer	3.57e-06	8.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.55e-06	8.67e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CREBBP—hematologic cancer	3.54e-06	8.67e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.52e-06	8.62e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.52e-06	8.62e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NUP214—hematologic cancer	3.5e-06	8.55e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.49e-06	8.54e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.49e-06	8.54e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.49e-06	8.53e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—FHL2—hematologic cancer	3.48e-06	8.5e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NUP214—hematologic cancer	3.47e-06	8.48e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SDC1—hematologic cancer	3.46e-06	8.47e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTT1—hematologic cancer	3.46e-06	8.46e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGF2—hematologic cancer	3.46e-06	8.45e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—hematologic cancer	3.44e-06	8.41e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.43e-06	8.39e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.43e-06	8.38e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.43e-06	8.38e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTR—hematologic cancer	3.43e-06	8.38e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AGRN—hematologic cancer	3.41e-06	8.34e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3R1—hematologic cancer	3.41e-06	8.34e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.4e-06	8.31e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTR—hematologic cancer	3.4e-06	8.31e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SDC1—hematologic cancer	3.38e-06	8.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ENO2—hematologic cancer	3.36e-06	8.22e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	3.36e-06	8.22e-05	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.36e-06	8.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ENO2—hematologic cancer	3.33e-06	8.15e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—MTHFR—hematologic cancer	3.32e-06	8.12e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—hematologic cancer	3.32e-06	8.11e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—JAK2—hematologic cancer	3.31e-06	8.1e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.31e-06	8.09e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	3.27e-06	7.99e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.27e-06	7.99e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.26e-06	7.97e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.24e-06	7.92e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MDM2—hematologic cancer	3.23e-06	7.91e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—IDH2—hematologic cancer	3.23e-06	7.91e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMMR—hematologic cancer	3.23e-06	7.91e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.23e-06	7.9e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CREBBP—hematologic cancer	3.19e-06	7.8e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SDC1—hematologic cancer	3.19e-06	7.79e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.18e-06	7.78e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.18e-06	7.77e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	3.17e-06	7.76e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SDC1—hematologic cancer	3.16e-06	7.72e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTOR—hematologic cancer	3.15e-06	7.69e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CB—hematologic cancer	3.15e-06	7.69e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD4—hematologic cancer	3.14e-06	7.68e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.13e-06	7.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.04e-06	7.43e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.03e-06	7.41e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.03e-06	7.41e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CD—hematologic cancer	3.02e-06	7.39e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.02e-06	7.38e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.01e-06	7.36e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3e-06	7.34e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—hematologic cancer	2.99e-06	7.3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.98e-06	7.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CA9—hematologic cancer	2.96e-06	7.23e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ACP5—hematologic cancer	2.96e-06	7.23e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1B—hematologic cancer	2.95e-06	7.22e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CD44—hematologic cancer	2.95e-06	7.2e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NQO1—hematologic cancer	2.95e-06	7.2e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.93e-06	7.16e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NCOR1—hematologic cancer	2.92e-06	7.14e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—hematologic cancer	2.92e-06	7.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.92e-06	7.14e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.88e-06	7.05e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NQO1—hematologic cancer	2.88e-06	7.03e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CD44—hematologic cancer	2.88e-06	7.03e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.87e-06	7.03e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3R1—hematologic cancer	2.86e-06	6.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.85e-06	6.97e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—hematologic cancer	2.84e-06	6.94e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.79e-06	6.83e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYCS—hematologic cancer	2.79e-06	6.82e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CREBBP—hematologic cancer	2.78e-06	6.8e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—IDH1—hematologic cancer	2.78e-06	6.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.77e-06	6.77e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TXN—hematologic cancer	2.75e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.75e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.75e-06	6.72e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—hematologic cancer	2.73e-06	6.66e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYCS—hematologic cancer	2.72e-06	6.65e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—hematologic cancer	2.72e-06	6.65e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.71e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NQO1—hematologic cancer	2.71e-06	6.62e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CD44—hematologic cancer	2.71e-06	6.62e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.7e-06	6.61e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.69e-06	6.58e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CD44—hematologic cancer	2.69e-06	6.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NQO1—hematologic cancer	2.69e-06	6.57e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.64e-06	6.45e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—hematologic cancer	2.64e-06	6.44e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.63e-06	6.43e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—hematologic cancer	2.6e-06	6.37e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EP300—hematologic cancer	2.59e-06	6.34e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.59e-06	6.33e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.58e-06	6.32e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.58e-06	6.31e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYCS—hematologic cancer	2.56e-06	6.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.55e-06	6.23e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYCS—hematologic cancer	2.54e-06	6.21e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.53e-06	6.19e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.53e-06	6.17e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—hematologic cancer	2.52e-06	6.17e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.51e-06	6.15e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.51e-06	6.15e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.5e-06	6.12e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.49e-06	6.09e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.49e-06	6.09e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.46e-06	6.01e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.45e-06	6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.45e-06	5.99e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—hematologic cancer	2.43e-06	5.95e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—NRAS—hematologic cancer	2.43e-06	5.93e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—hematologic cancer	2.42e-06	5.92e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—EP300—hematologic cancer	2.41e-06	5.9e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—hematologic cancer	2.4e-06	5.86e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.38e-06	5.81e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NUP98—hematologic cancer	2.37e-06	5.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.33e-06	5.69e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK3—hematologic cancer	2.32e-06	5.68e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.32e-06	5.67e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.3e-06	5.63e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.3e-06	5.63e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.3e-06	5.62e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NUP214—hematologic cancer	2.29e-06	5.59e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—hematologic cancer	2.28e-06	5.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.27e-06	5.56e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—hematologic cancer	2.26e-06	5.53e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.26e-06	5.53e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.26e-06	5.52e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.26e-06	5.52e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—hematologic cancer	2.25e-06	5.51e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTR—hematologic cancer	2.24e-06	5.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.24e-06	5.48e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.24e-06	5.48e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NCOR1—hematologic cancer	2.2e-06	5.39e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—hematologic cancer	2.2e-06	5.39e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ENO2—hematologic cancer	2.2e-06	5.37e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—EP300—hematologic cancer	2.17e-06	5.31e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.17e-06	5.3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.17e-06	5.3e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.16e-06	5.29e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.14e-06	5.23e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.14e-06	5.23e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.13e-06	5.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.12e-06	5.19e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—hematologic cancer	2.09e-06	5.11e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SDC1—hematologic cancer	2.08e-06	5.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.08e-06	5.08e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.08e-06	5.08e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—EP300—hematologic cancer	2.06e-06	5.05e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.06e-06	5.03e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.06e-06	5.03e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.01e-06	4.92e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—hematologic cancer	2e-06	4.88e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—hematologic cancer	1.99e-06	4.86e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—hematologic cancer	1.95e-06	4.76e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—hematologic cancer	1.92e-06	4.69e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.91e-06	4.66e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—EP300—hematologic cancer	1.89e-06	4.63e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—hematologic cancer	1.88e-06	4.6e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—hematologic cancer	1.85e-06	4.52e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.84e-06	4.49e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.82e-06	4.45e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.8e-06	4.4e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.79e-06	4.37e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—hematologic cancer	1.78e-06	4.34e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NQO1—hematologic cancer	1.77e-06	4.33e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CD44—hematologic cancer	1.77e-06	4.33e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—EP300—hematologic cancer	1.76e-06	4.31e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.76e-06	4.3e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—hematologic cancer	1.7e-06	4.15e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.68e-06	4.1e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYCS—hematologic cancer	1.68e-06	4.1e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.67e-06	4.07e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.66e-06	4.06e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.64e-06	4e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.61e-06	3.93e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.6e-06	3.92e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—hematologic cancer	1.57e-06	3.83e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.55e-06	3.8e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.54e-06	3.77e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.53e-06	3.74e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.53e-06	3.73e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CREBBP—hematologic cancer	1.52e-06	3.71e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.48e-06	3.61e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.47e-06	3.6e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.46e-06	3.57e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—hematologic cancer	1.46e-06	3.56e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.44e-06	3.52e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—hematologic cancer	1.44e-06	3.51e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.43e-06	3.5e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—hematologic cancer	1.42e-06	3.47e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.42e-06	3.47e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.4e-06	3.43e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.4e-06	3.42e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.39e-06	3.4e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—EP300—hematologic cancer	1.37e-06	3.35e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.36e-06	3.32e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.36e-06	3.32e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.36e-06	3.32e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.36e-06	3.31e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.34e-06	3.29e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—hematologic cancer	1.34e-06	3.27e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—hematologic cancer	1.33e-06	3.24e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—hematologic cancer	1.31e-06	3.21e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.3e-06	3.19e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.28e-06	3.14e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.28e-06	3.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.27e-06	3.1e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.25e-06	3.07e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.25e-06	3.05e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.2e-06	2.93e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.18e-06	2.89e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.17e-06	2.86e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—hematologic cancer	1.14e-06	2.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—hematologic cancer	1.11e-06	2.71e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—hematologic cancer	1.08e-06	2.65e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—hematologic cancer	1.07e-06	2.6e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—EP300—hematologic cancer	1.06e-06	2.59e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—EP300—hematologic cancer	1.03e-06	2.53e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—hematologic cancer	1.02e-06	2.5e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.01e-06	2.48e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—hematologic cancer	1.01e-06	2.47e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.01e-06	2.47e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—EP300—hematologic cancer	9.74e-07	2.38e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—EP300—hematologic cancer	9.65e-07	2.36e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.35e-07	2.29e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.86e-07	2.17e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—hematologic cancer	8.75e-07	2.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.37e-07	2.05e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—hematologic cancer	8.28e-07	2.02e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—hematologic cancer	7.83e-07	1.91e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.73e-07	1.89e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.64e-07	1.87e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.2e-07	1.76e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.14e-07	1.75e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—hematologic cancer	6.68e-07	1.63e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—hematologic cancer	6.4e-07	1.56e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—EP300—hematologic cancer	6.37e-07	1.56e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—hematologic cancer	6.24e-07	1.53e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—hematologic cancer	5.88e-07	1.44e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—hematologic cancer	5.83e-07	1.43e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.71e-07	1.15e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—hematologic cancer	3.85e-07	9.41e-06	CbGpPWpGaD
